Hepatitis C Virus Markers in Patients With Acute Post-Transfusion Hepatitis Treated With Interferon Alfa-2b.

Gut - United Kingdom
doi 10.1136/gut.34.2_suppl.s62
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Treatment of Chronic Hepatitis C With Recombinant Interferon Alfa-2b for Nine Months.

Gut
Gastroenterology
1993English

Peginterferon Alfa-2b and Ribavirin Therapy in Kuwaiti Patients With Chronic Hepatitis C Virus Infection

Eastern Mediterranean Health Journal
Medicine
2011English

Incidence of Thyroid Dysfunction During Interferon Alfa-2b and Ribavirin Therapy in Men With Chronic Hepatitis C

Archives of Internal Medicine
2004English

Oxidative Stress and Antioxidant Defense in Patients With Chronic Hepatitis C Patients Before and After Pegylated Interferon Alfa-2b Plus Ribavirin Therapy

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2006English

The Course of Inactive Hepatitis B in Hepatitis-C-Coinfected Patients Treated With Interferon and Ribavirin

Antiviral Therapy
Infectious DiseasesPharmacology
2009English

Sustained Virologic Response and IL28B Single-Nucleotide Polymorphisms in Patients With Chronic Hepatitis C Treated With Pegylated Interferon Alfa and Ribavirin.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2012English

Quasispecies of Genotype 4 of Hepatitis C Virus Genomes in Saudi Patients Managed With Interferon Alfa and Ribavirin Therapy

Annals of Saudi Medicine
Medicine
2010English

Low Dose Interferon Alfa-2b for Chronic Hepatitis B in Asian Countries.

Gut
Gastroenterology
1993English

Hepatitis B Reactivation in Chronic Hepatitis C Patients Treated With Interferon or Pan-Oral Direct-Acting Antivirals

Hepatology
MedicineHepatology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy